Part 11 Risk-Based Approach To Be Communicated To FDA Field Staff
This article was originally published in The Gray Sheet
Executive Summary
Device manufacturers should prepare for variability in how inspectors interpret Part 11 requirements as FDA gears-up to communicate more specific guidelines to its field staff in the next several weeks